Class information for:
Level 1: IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//RADIATION THERAPY COMPLICATIONS//STANDARDIZED INCIDENCE RATE

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
13107 796 30.2 75%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1619 6500 ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS Author keyword 4 75% 0% 3
2 RADIATION THERAPY COMPLICATIONS Author keyword 2 67% 0% 2
3 STANDARDIZED INCIDENCE RATE Author keyword 2 67% 0% 2
4 AGE RISK Author keyword 1 50% 0% 2
5 CERVICAL HUMAN PAPILLOMAVIRUS INFECTION Author keyword 1 50% 0% 2
6 FAMILY COMMUNITY MED STOCKHOLM Address 1 50% 0% 2
7 IMMUNE DISTURBANCE Author keyword 1 33% 0% 2
8 ACTIVATED FIBROBLAST Author keyword 1 50% 0% 1
9 ALLERGY CLIN EPIDEMIOL Address 1 50% 0% 1
10 ANTI TUMOR NECROSIS FACTOR TNF AGENTS Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
LCSH search Wikipedia search
1 IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS 4 75% 0% 3 Search IMMUNODEFICIENCY+ASSOCIATED+LYMPHOPROLIFERATIVE+DISORDERS Search IMMUNODEFICIENCY+ASSOCIATED+LYMPHOPROLIFERATIVE+DISORDERS
2 RADIATION THERAPY COMPLICATIONS 2 67% 0% 2 Search RADIATION+THERAPY+COMPLICATIONS Search RADIATION+THERAPY+COMPLICATIONS
3 STANDARDIZED INCIDENCE RATE 2 67% 0% 2 Search STANDARDIZED+INCIDENCE+RATE Search STANDARDIZED+INCIDENCE+RATE
4 AGE RISK 1 50% 0% 2 Search AGE+RISK Search AGE+RISK
5 CERVICAL HUMAN PAPILLOMAVIRUS INFECTION 1 50% 0% 2 Search CERVICAL+HUMAN+PAPILLOMAVIRUS+INFECTION Search CERVICAL+HUMAN+PAPILLOMAVIRUS+INFECTION
6 IMMUNE DISTURBANCE 1 33% 0% 2 Search IMMUNE+DISTURBANCE Search IMMUNE+DISTURBANCE
7 ACTIVATED FIBROBLAST 1 50% 0% 1 Search ACTIVATED+FIBROBLAST Search ACTIVATED+FIBROBLAST
8 ANTI TUMOR NECROSIS FACTOR TNF AGENTS 1 50% 0% 1 Search ANTI+TUMOR+NECROSIS+FACTOR+TNF+AGENTS Search ANTI+TUMOR+NECROSIS+FACTOR+TNF+AGENTS
9 ANTITOPOISOMERASE 1 50% 0% 1 Search ANTITOPOISOMERASE Search ANTITOPOISOMERASE
10 ATYPICAL LYMPHOPLASMACYTIC AND IMMUNOBLASTIC PROLIFERATION 1 50% 0% 1 Search ATYPICAL+LYMPHOPLASMACYTIC+AND+IMMUNOBLASTIC+PROLIFERATION Search ATYPICAL+LYMPHOPLASMACYTIC+AND+IMMUNOBLASTIC+PROLIFERATION

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 REVERSIBLE LYMPHOMAS 8 60% 1% 9
2 LYMPHOMA RISK 4 35% 1% 9
3 FAMILIAL RISKS 3 24% 1% 11
4 COLLAGEN VASCULAR DISEASES 2 12% 2% 14
5 CANCER MORBIDITY 1 20% 1% 4
6 EXCESS RISK 1 13% 1% 5
7 RARE ASSOCIATION 1 16% 1% 4
8 COMMON COMPLEX DISEASES 1 50% 0% 1
9 ESTIMATING RISKS 1 50% 0% 1
10 HIP REPLACEMENT PATIENTS 1 50% 0% 1

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review 2015 1 16 69%
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 2014 10 33 64%
The risk of lymphoma development in autoimmune diseases - A meta-analysis 2005 255 53 45%
Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review 2011 21 30 73%
Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature 2009 30 32 81%
A systematic review of the incidence and prevalence of cancer in multiple sclerosis 2015 1 37 30%
Lupus and cancer 2009 35 66 68%
Epstein-Barr Virus-Positive Oral Ulceration Simulating Hodgkin Lymphoma in a Patient Treated With Methotrexate: Case Report and Review of the Literature 2014 3 15 87%
Systemic lupus and malignancies 2012 9 32 84%
Multiple Associations Between a Broad Spectrum of Autoimmune Diseases, Chronic Inflammatory Diseases and Cancer 2012 44 127 24%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 FAMILY COMMUNITY MED STOCKHOLM 1 50% 0.3% 2
2 ALLERGY CLIN EPIDEMIOL 1 50% 0.1% 1
3 AUTOIMMUNE MUSCULOSKELETAL 1 50% 0.1% 1
4 CANADIAN ARTHRIT NETWORK 1 50% 0.1% 1
5 CLIN CONNECT TISSUE DIS 1 50% 0.1% 1
6 EPIDEMIOL REGISTRE CANC 1 50% 0.1% 1
7 EPIDEMOL BIOSTAT 1 50% 0.1% 1
8 HGR 45 1 50% 0.1% 1
9 IE3M 1 50% 0.1% 1
10 INVEST BIOMED BIOPATOL MED REGENERAT 1 50% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000178935 CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN
2 0.0000167490 PARANEOPLASTIC VASCULITIS//PALMAR FASCIITIS//LEUKEMIC ARTHRITIS
3 0.0000135761 DS DNA ANTIBODIES//INTERNAL AUTOIMMUNE METAB DIS//CHU PITIE SALPETRIERE HP
4 0.0000106278 SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS
5 0.0000100818 NON HODGKIN//ENVIRONM EPIDEMIOL CANC GRP//EPIDEMIOL GENET UNIT
6 0.0000074264 METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68
7 0.0000070841 ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS
8 0.0000069283 SARCOID LIKE REACTION//SARCOID REACTION//SARCOIDOSIS LYMPHOMA SYNDROME
9 0.0000062892 SHIITAKE DERMATITIS//FLAGELLATE DERMATITIS//FLAGELLATE ERYTHEMA
10 0.0000061255 DRUG INDUCED LUPUS//DRUG INDUCED LUPUS ERYTHEMATOSUS//TNF ALPHA ANTAGONISTS